Author(s):
Pallavi M. Patil, Vitthal V. Chopade, Surbhi C. Gupta
Email(s):
Email ID Not Available
DOI:
10.52711/0974-360X.2023.00607 
Address:
Pallavi M. Patil*, Vitthal V. Chopade, Surbhi C. Gupta
P.E. Society’s Modern College of Pharmacy, Yamunanagar, Nigdi, Pune - 411044 Maharashtra, India, 411044.
*Corresponding Author
Published In:
Volume - 16,
Issue - 8,
Year - 2023
ABSTRACT:
Investigations on chemical behaviour of Acyclovir (ACY) are essential for determining stability properties during processing and storage conditions. The present work describes the stability and decomposition kinetics of ACY by using a stability indicating HPLC method. The experiments were designed with quality by design (QbD) approach to facilitate method development and optimization. Different stress conditions including hydrolytic (acid, base, neutral), oxidative, thermal and photolytic degradation were applied. Stability analysis reveals that relevant degradation occurs in all applied conditions. The proposed method was linear with precision and robustness values within acceptable limits.Under employed experimental conditions, the degradation of ACY followed (pseudo) first-order kinetics. The kinetic parameters (rate constant, t1/2, and t90) of the degradation of ACY were calculated.
Cite this article:
Pallavi M. Patil, Vitthal V. Chopade, Surbhi C. Gupta. Analytical Quality by Design (QbD) Approach for Development and Validation of HPLC Method for Acyclovir: Application Degradation Kinetics. Research Journal of Pharmacy and Technology 2023; 16(8):3691-6. doi: 10.52711/0974-360X.2023.00607
Cite(Electronic):
Pallavi M. Patil, Vitthal V. Chopade, Surbhi C. Gupta. Analytical Quality by Design (QbD) Approach for Development and Validation of HPLC Method for Acyclovir: Application Degradation Kinetics. Research Journal of Pharmacy and Technology 2023; 16(8):3691-6. doi: 10.52711/0974-360X.2023.00607 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-8-27
REFERENCES:
1. O’Brien JJ. Campoli-Richards DM. Acyclovir an updated review of its antiviral activity, pharmacokinetics properties and therapeutic efficacy. Drugs. 1989;37:233-309. https://doi.org/10.2165/00003495-198937030-00002
2. Arnal J. Gonzalez-alvarez I. Bermejo M. Amidon GL. Junginger HE. Kopp S. et al. Biowaiver monographs for immediate release solid oral dosage forms: Acyclovir. J. Pharm. Sci. 2008; 97:5061-73. https://doi.org/10.1002/jps.21392
3. Wagstaff AJ. Faulds D. Goa KL. Acyclovir: a reappraisal of its antiviral activity pharmacokinetic properties and therapeutic effic of ACY. Drugs. 1994; 47:153-205. https://doi.org/10.2165/00003495-199447010-00009
4. Fletcher C. Bean B. Evaluation of oral Acyclovir therapy. Drug Intell.Clin. Pharm. 1985; 19:518-24. https://doi.org/10.1177/106002808501900703
5. Tadepalli SM. Quinn RP. Averett DR. A competitive enzyme-linked immunosorbent assay to quantitate Acyclovir and BW B759U in human plasma and urine Antimicrob. Agents. Chemother. 1986; 29:93-98. https://doi.org/10.1177/106002808501900703
6. Bahrami G. Mirzaeei S. Kiani A. Determination of aciclovir in human serum by high-performance liquid chromatography using liquid-liquid extraction and its application in pharmacokinetic studies. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2005;816:327-331. https://doi.org/10.1016/j.jchromb.2004.11.038
7. Land G. Bye A. Simple high performance liquid chromatography method for the analysis of (9-2 hydroxyethxymethyl guanine (Acyclovir) in human and urine sample). J. Chromatogr.B. 1981; 224: 51–58. https://doi.org/10.1016/s0378-4347(00)80137-1
8. Peh KK. Yuen KH. Simple high-performance liquid chromatographic method for the determination of Acyclovir in human plasma using fluorescence detection. J.Chromatogr. B. Biomed. Sci. Appl. 1997; 693:241-244. https://doi.org/10.1016/s0378-4347(97)00041-8
9. International conference on hormonization, 2003. Stability testing of new drug substances and products Q1A (R2). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A R2/Step4/Q1A_R2 Guideline.pdf. (Accessed 28.12.2016)
10. Rajeev Garg, GD Gupta. Development and Characterization of Cellulose and Eudragit Gastroretentive Floating Microspheres of Acyclovir. Research J. Pharm. and Tech. 2009; 2:101-105.
11. Kishore UK, Prashant Kesharwani, Suresh K G, Paraag GA. Development and Characterization of Chitosan Nanoparticles and Improvement of Oral Bioavailability of Poorly Water-Soluble Acyclovir. Research J. Pharm. and Tech. 2010; 4: 1241-1245.
12. Rajesh B. Nawale, Uday A. Deokate, Sadhana R. Shahi, Pradeep M. Lokhande. Formulation and Characterization of Efavirenz Nanosuspension by QbD approach. Research J. Pharm. and Tech 2017; 10:2960-2972.doi: 10.5958/0974-360X.2017.00525.X